A new KFF health tracking survey found that one in eight U.S. adults have taken Ozempic or a similar GLP-1 drug at some point ...
JUST 6% OF US ... DRUGS THAN THOSE WITH PRIVATE INSURANCE. EXPERTS SAY THE LACK OF ACCESSIBILITY MEANS MANY PEOPLE TURN TO ...
KFF poll results suggest about 12 percent of adults in the U.S. have tried a GLP-1 drug like Ozempic to manage chronic health ...
The majority — 62 percent — said they were using the drugs to treat a chronic condition like diabetes or heart disease while ...
JUST 6% OF US ADULTS WITH DIABETES ... AND THOSE WHO CAN GET ACCESS TO THE DRUG SOMETIMES HAVE TO STOP BECAUSE OF About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic ...
About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half of them – about 6% of adults, or more than 15 million people – are ...